{
  "ptid_time": "021_S_4335_2011-11-11",
  "img_path": "/data/qiuhui/data/adni/images/021_S_4335/2011-11-11/t1.nii.gz",
  "img_finding": "Image findings: ventricular volume measures 17,761 mm³, 36.7% below the reference mean. With a Z-score of -0.84 (20.0th percentile), this represents normal volume ; hippocampal volume measures 8,184 mm³, 15.0% above the reference mean. With a Z-score of 1.38 (91.6th percentile), this represents mild enlargement; whole brain volume measures 1,087,370 mm³, 11.6% above the reference mean. With a Z-score of 1.46 (92.7th percentile), this represents mild enlargement; entorhinal cortex volume measures 4,426 mm³, 20.5% above the reference mean. With a Z-score of 1.26 (89.6th percentile), this represents mild enlargement; fusiform gyrus volume measures 21,203 mm³, 24.6% above the reference mean. With a Z-score of 2.24 (98.7th percentile), this represents significant enlargement; middle temporal gyrus volume measures 22,808 mm³, 19.0% above the reference mean. With a Z-score of 1.65 (95.0th percentile), this represents moderate enlargement. ",
  "text_data": "Age is 71.7 years. Gender is Female. Education: 15 years. Handedness: Right. Race: White. Medical history: Head, Eyes, Ears, Nose and Throat; Cardiovascular; Musculoskeletal; Endocrine-Metabolic; Gastrointestinal; Renal-Genitourinary; Smoking; Malignancy. MMSE: 30.0. MoCA: 27.0. Logical Memory: 14.0. Laboratory findings: Lymphocytes: 2.83 (significant elevated); AST (SGOT): 33.00 (significant elevated). APOEε4 alleles: 0.0. Biomarker levels: Florbetapir (AV45): 1.24 SUVR (mild elevated); Amyloid beta: 203.00 pg/mL (significant reduced); Total tau: 153.90 pg/mL (mild reduced); Phosphorylated tau: 16.11 pg/mL (normal ). ",
  "true_diagnosis": "Diagnosis: CN.",
  "gpt_diagnosis": "**Reasoning:** The brain volume data shows mild to significant enlargement in multiple regions (hippocampus, whole brain, entorhinal cortex, fusiform gyrus, middle temporal gyrus), which is atypical for Alzheimer's disease (AD). The ventricular volume is normal, further reducing concern for atrophy. Clinically, the patient has normal cognition (MMSE 30, MoCA 27), no APOE4 risk allele, and inconsistent AD biomarkers (Aβ reduced but T-tau mildly reduced, P-tau normal, AV45 mildly elevated).  \n\n**Diagnosis:** **CN (Cognitively Normal)**  \n**Confidence:** **Medium** (Biomarker inconsistencies and atypical volumetric findings warrant caution, but cognitive scores strongly support normal status.)",
  "timestamp": "2025-07-26T01:44:06.998519"
}